The reference framework for diabetes care in primary care settings

Hong Kong Medical Journal

Volumn 18, Issue 3, 2012, Pages 238-246

  Wong, Martin C S ^a   Sin, Cecilia K L ^a,b   Lee, Jeff P M ^a,b  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b Primary Care Office   (Hong Kong)

Author keywords

Diabetes mellitus; Hong Kong; Prevalence; Risk factors

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLITAZONE DERIVATIVE; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; HEMOGLOBIN A1C; INSULIN; MEGLITINIDE; METFORMIN; SULFONYLUREA DERIVATIVE;

ARTICLE; CARDIOVASCULAR RISK; COMBINATION CHEMOTHERAPY; COMMUNITY BASED REHABILITATION; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIET THERAPY; DISEASE CONTROL; DRUG COST; DRUG MECHANISM; EARLY DIAGNOSIS; EMPOWERMENT; EXERCISE; EYE EXAMINATION; FLUID RETENTION; FOOT CARE; FRACTURE; GASTROINTESTINAL SYMPTOM; GLYCEMIC CONTROL; HEART FAILURE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; KIDNEY FUNCTION; LACTIC ACIDOSIS; MONOTHERAPY; ORAL GLUCOSE TOLERANCE TEST; PATIENT ASSESSMENT; PATIENT EDUCATION; PATIENT MONITORING; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PROPHYLAXIS; PUBLIC-PRIVATE PARTNERSHIP; SCREENING; SIDE EFFECT; WEIGHT GAIN;

DIABETES COMPLICATIONS; DIABETES MELLITUS; DISEASE MANAGEMENT; HONG KONG; HUMANS; PRIMARY HEALTH CARE; RISK FACTORS;

EID: 84862586269     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Primary care initiatives. Reference frameworks. Department of Health, Primary Care Office website: http://www.pco.gov.hk/english/initiatives/frameworks.html. Accessed 12 Oct 2011.
2. Hong Kong reference framework for diabetes care for adults in primary care settings. Department of Health, Primary Care Office website: http://www.pco.gov.hk/english/resource/files/RF_DM_full.pdf. Accessed 12 Oct 2011.
3. Diabetes atlas. Epidemiology and morbidity. 2011. International Diabetes Federation website: http://www.diabetesatlas.org/content/epidemiology-and-morbidity. Accessed 12 Oct 2011.
4. Diamond J. The double puzzle of diabetes. Nature 2003;423:599-602.
5. 2011 High Level Meeting on Prevention and Control of Non-communicable Diseases. General Assembly, United Nations, New York, 19-20 September, 2011. United Nations website: http://www.un.org/en/ga/ncdmeeting2011/webcast.shtml. Accessed 12 Oct 2011.
6. Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009;301:2129-40.
7. Janus ED, Watt NM, Lam KS, et al. The prevalence of diabetes, association with cardiovascular risk factors and implications of diagnostic criteria (ADA 1997 and WHO 1998) in a 1996 community-based population study in Hong Kong Chinese. Hong Kong Cardiovascular Risk Factor Steering Committee. American Diabetes Association. Diabet Med 2000;17:741-5.
8. Wong KC, Wang Z. Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan. Diabetes Res Clin Pract 2006;73:126-34.
9. Diabetes Hongkong. Response to the "Your Health, Your Life". Healthcare Reform Consultation June 2008. Hong Kong Food and Health Bureau website: http://www.fhb.gov.hk/beStrong/files/organizations/O017.pdf. Accessed 1 Oct 2011.
10. Kumar P, Clark M. Diabetes mellitus and other disorders of metabolism. In: Clinical medicine. 5th ed. London: Saunders; 2002.
11. Roglic G, Unwin N, Bennett PH, et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care 2005;28:2130-5.
12. The World Health Report 2008: Primary health care now more than ever. World Health Organization website: http://www.who.int/whr/2008/whr08_en.pdf. Accessed 1 Oct 2011.
13. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ, editors. Global burden of disease and risk factors. New York: Oxford University Press and Washington DC: The World Bank; 2006. Disease Control Priorities Project website: http://www.dcp2.org/pubs/GBD. Accessed 1 Oct 2011.
14. Diabetes prevention: population approach. Brussels: International Diabetes Federation; 2009. International Diabetes Federation website: http://www.idf.org/diabetesprevention/population-approach. Accessed 1 Oct 2011.
15. Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.
16. Franz MJ, Monk A, Barry B, et al. Effectiveness of medical nutrition therapy provided by dietitians in the management of non-insulin-dependent diabetes mellitus: a randomized, controlled clinical trial. J Am Diet Assoc 1995;95:1009-17.
17. Goldhaber-Fiebert JD, Goldhaber-Fiebert SN, Tristán ML, Nathan DM. Randomized controlled community-based nutrition and exercise intervention improves glycemia and cardiovascular risk factors in type 2 diabetic patients in rural Costa Rica. Diabetes Care 2003;26:24-9.
18. Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Lau J. Long-term non-pharmacological weight loss interventions for adults with prediabetes. Cochrane Database Syst Rev 2005; (2):CD005270.
19. Manson JE, Nathan DM, Krolewski AS, Stampfer MJ, Wilett WC, Hennekens CH. A prospective study of exercise and incidence of diabetes among US male physicians. JAMA 1992;268:63-7.
20. Lynch J, Helmrich SP, Lakka TA, et al. Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle aged men. Arch Intern Med 1996;156:1307-14.
21. Burchfiel CM, Sharp DS, Curb JD, et al. Physical activity and incidence of diabetes: the Honolulu Heart Program. Am J Epidemiol 1995;141:360-8.
22. IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med 2006;23:579-93.
23. American Diabetes Association. Standard of medical care in Diabetes-2010. Diabetic Care 2010;33 (Suppl):11S-61S.
24. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Canadian Journal of Diabetes 2008; 32(Suppl):1S-201S.
25. The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: national clinical guideline for management in primary and secondary care (update). London (UK): Royal College of Physicians; 2008. National Institute for Health and Clinical Excellence website: http://www.nice.org.uk/nicemedia/pdf/CG66FullGuideline0509.pdf. Accessed 1 Oct 2011.
26. Hong Kong Scientific Committee on Vaccine Preventable Disease. Recommendations on seasonal influenza vaccination for the 2010/11 season. Hong Kong Centre for Health Protection website: http://www.chp.gov.hk/files/pdf/recommendations_on_seasonal_influenza_vaccination_for_the_2010_11_season_eng.pdf. Accessed 1 Oct 2011.
27. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53.
28. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12.
29. International Diabetes Federation Western Pacific Region Type 2 Diabetes Practical Treatments and Targets. 4th ed. Asian-Pacific Type 2 Diabetes Policy Group; 2005.
30. Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203.
31. Rodbard HW, Jellinger PS, Davidson JA, et al. Statement by an American Association of Clinical Endocrinologists/ American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract 2009;15: 540-59. Erratum in: Endocr Pract 2009;15:768-70.
32. Strippoli GF, Craig MC, Schena FP, Craig JC. Role of blood pressure targets and specific antihypertensive agents used to prevent diabetic nephropathy and delay its progression. J Am Soc Nephrol 2006;17(4 Suppl 2):S153-5.
33. Parving HH, Lehnert H, Bröchner-Mortensen J, Gomis R, Andersen S, Arner P; Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001;345:870-8.
34. Rossing K, Schjoedt KJ, Jensen BR, Boomsma F, Parving HH. Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria. Kidney Int 2005;68:1190-8.
35. Hutchinson A, McIntosh A, Peters J, et al. Effectiveness of screening and monitoring tests for diabetic retinopathy-a systematic review. Diabet Med 2000;17:495-506.
36. Taylor R. Practical community screening for diabetic retinopathy using the mobile retinal camera: report of a 12 centre study. British Diabetic Association Mobile Retinal Screening Group. Diabet Med 1996;13:946-52.
37. Harding SP, Broadbent DM, Neoh C, White MC, Vora J. Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool Diabetic Eye Study. BMJ 1995;311:1131-5.
38. Murgatroyd H, Ellingford A, Cox A, et al. Effect of mydriasis and different field strategies on digital image screening of diabetic eye disease. Br J Ophthalmol 2004;88:920-4.
39. Guidelines for diabetic retinopathy. London: The Royal College of Ophthalmologists; 2005. The Royal College of Ophthalmologists website: http://www.rcophth.ac.uk/docs/publications/published-guidelines/DiabeticRetinopathyGuidelines2005.pdf. Accessed 1 Oct 2011.
40. Murphy RP, Egbert PR. Regression of iris neovascularization following panretinal photocoagulation. Arch Ophthalmol 1979;97:700-2.
41. Boulton AJ, Armstrong DG, Albert SF, et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care 2008;31:1679-85.
42. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 2003;26:3333-41.